Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study

1. Monin, L.
2. Laing, A.G.
3. Muñoz-Ruiz, M.
4. McKenzie, D.R.
5. del Molino del Barrio, I.
6. Alaguthurai, T.
7. Domingo-Vila, C.
8. Hayday, T.S.
9. Graham, C.
10. Seow, J.
11. Abdul-Jawad, S.
12. Kamdar, S.
13. Harvey-Jones, E.
14. Graham, R.
15. Cooper, J.
16. Khan, M.
17. Vidler, J.
18. Kakkassery, H.
19. Sinha, S.
20. Davis, R.
21. Dupont, L.
22. Francos Quijorna, I.
23. O'Brien-Gore, C.
24. Lee, P.L.
25. Eum, J.
26. Conde Poole, M.
27. Joseph, M.
28. Davies, D.
29. Wu, Y.
30. Swampillai, A.
31. North, B.V.
32. Montes, A.
33. Harries, M.
34. Rigg, A.
35. Spicer, J.
36. Malim, M.H.
37. Fields, P.
38. Patten, P.
39. Di Rosa, F.
40. Papa, S.
41. Tree, T.
42. Doores, K.J.
43. Hayday, A.C.
44. Irshad, S.
45. Show all authors +

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1016/S1470-2045(21)00213-8 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus